45 episodes
Life Sciences 360 Harsh Thakkar
-
- Science
Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the show both informative and useful.
-
AI in Life Sciences: Should You Follow This Trend?
Welcome to episode 045 of Life Sciences 360.
On this episode, Nagesh Nama and his team at XLM talk on why Gen.AI is essential in the software test world and share examples of its use in various industries, particularly in life sciences and manufacturing. They address the challenges faced by companies in adopting AI and provide solutions for integrating AI into existing systems.
Harsh and his guests discuss how AI can improve productivity, enhance quality assurance processes, and enable proactive decision-making. The conversation emphasizes the importance of having an AI strategy and encourages SMBs to embrace AI to gain a competitive advantage.
-----
Links:
* Nagesh Nama LinkedIn
* xLM LinkedIn
*xLM website
*Harsh Thakkar LinkedIn
*Would you rather watch this episode? Click here for the YouTube episode.
👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel Life Sciences 360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.
-----
Show Notes:
(0:00) Human vs. AI Diagnosis
(4:40) Using AI to Automate Clinical Trial Management Systems
(8:18) Challenges of AI adoption & Data Integrity
(13:55) Affordable AI Validation Services for SMBs
(17:55) New Companies Add AI Features, Chat GPT Stays Ahead
(21:58) How To Increase Productivity & Improve Compliance
(26:44) XLM's AI Powered Platform
(30:45) AI in Pharma
(34:57) Using AI for Supply Chain Management
For more, check out the podcast website - www.lifesciencespod.com -
The NASA Scientist Who Changed Cancer Diagnostics Forever
Dr. Arnon Chait, CEO of Cleveland Diagnostics, discusses his transition from NASA to the healthcare innovation space and the development of cancer diagnostics.
Dr. Chait emphasizes the importance of using diagnostic advancements to strike a balance between over-screening and under-treating, particularly in the workup of cancer after failed screenings. He discusses the development of their innovative prostate cancer diagnostic test.
In Episode 044 of Life Sciences 360, Harsh and Arnon also emphasize the importance of asking the right questions in scientific research and the need for simple and actionable diagnostic tools in healthcare. They advise individuals to stay curious and interested in order to be productive and successful.
-----
Links:
*Arnon LinkedIn
*Cleveland Diagnostics
*Harsh Thakkar LinkedIn
*Would you rather watch on YouTube, Click HERE
👍 Like this video if you enjoy deep dives into healthcare innovations.
🔔 Subscribe to our channel Life Sciences 360 for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors and Leave us a Review.
-----
Show Notes:
(00:00) Introduction and Background
(06:26) Choosing Cleveland as a Startup Location
(13:13) Balancing Over-Screening and Under-Treating in Cancer Diagnostics
(18:57) Proteins Involved in the Disease Process
(26:41) The Importance of a Solution that Fits the Final Application
(29:05) The Power of Curiosity and Interest in a Career
(31:18) Final Thoughts and Advice
For more, check out the podcast website - www.lifesciencespod.com -
How On-Demand Cleanrooms Can Speed Up Drug Development
With the market estimated to reach $11.5 billion by 2028. Clean Rooms on Demand is providing flexible and cost-effective solutions for biotech and pharma companies.
The benefits of using clean rooms on demand include avoiding the high capital outlay and ongoing operational expenses of building and maintaining their own facilities, as well as the flexibility to scale up or down as needed.
Join me in Episode 43 of Life Sciences 360, with Sarah Stevens, the President of Azzur Labs and Azzur Cleanrooms on Demand, part of Azzur Group
-----
Links:
*Sarah Stevens LinkedIn
*Azzur Group
*Harsh Thakkar LinkedIn
*Would you rather watch? Click here.
-----
Show Notes:
(0:00) The Growing Cleanroom Technology Market
(3:29) Benefits of Cleanrooms on Demand
(6:41) A broader view of biotech lab solutions
(9:02) Customer Case Studies and Segments
(12:22) Expansion and Future Plans of Azzur Labs
(14:29) Global Expansion and Strategic Vision
(16:47) Sarah Stevens' Personal Career Journey
(21:26) The Azzur Culture and Team Dynamics
For more, check out the podcast website - www.lifesciencespod.com -
Beyond the Pill: When Medicine Meets Mindset with CEO, Will Hind
How can behavioral science optimize pharmaceutical practices?
Episode 042: Will Hind, CEO of Alpharmaxim Healthcare Communications, discusses the challenges and opportunities in integrating behavioral science with pharma strategies.
Find out how this can lead to better patient outcomes and more tailored healthcare solutions.
-----
Links:
*Will Hind LinkedIn
*Will Hind X
*Alpharmaxim
*Harsh Thakkar LinkedIn
*Would you rather watch the episode? Click here!
📝 Leave us a review!
🔔 Subscribe to our channel, Life Sciences 360, for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.
-----
Show Notes:
(0:00) Introduction to Behavioral Science in Pharma
(1:33) Why is behavior important in pharma?
(3:09) Data Analysis and Behavioral Science
(6:50) Breaking Down Barriers with Behavioral Science
(9:44) The Biggest Misconception of Behavioral Sciences
(10:52) Research & Clinical Trials
(14:49) The COM-B Model and Pharma Communication
(17:52) Multi-stakeholder Influence on Drug Adoption
(22:33) Role of Behavioral Science in Omni-channel Marketing
(26:21) Future of Behavioral Science in Pharma
For more, check out the podcast website - www.lifesciencespod.com -
The 3 Most Important Pillars of a Next-Generation CDMO, Explained!
Episode 041: J.D. Mowery, President and CEO of KBI Biopharma, discusses his career journey and the role of CDMOs in the biotech and pharma industry. He emphasizes the importance of relationships, risk-taking, and continuous learning in his career success.
J.D. highlights the unique combination of expertise required to work in both biotech and CDMO companies. He explains the challenges faced by biotech and pharma companies that have led to the rise of CDMOs.
Harsh asks J.D. to share the key factors to consider when selecting a CDMO. They introduce the concept of a next-generation CDMO, focusing on regulatory leadership, R&D and innovation, and risk sharing.
-----
Links:
*J.D. Mowery LinkedIn
*KBI Biopharma
*Harsh Thakkar LinkedIn
*Would you rather watch the episode? Click here!
📝 Leave us a review!
🔔 Subscribe to our channel, Life Sciences 360, for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.
-----
Show Notes:
(0:00) Intro to J.D. Mowery &KBI Biopharma
(3:49) J.D.'s Journey from Biotech to CDMO
(7:17) Biopharma Challenges driving the CDMO trend
(11:47) What to Look for in a CDMO
(14:18) The 3 MOST important pillars of next-gen CDMO
(22:05) Team Leadership & Culture at KBI
(25:28) What J.D. looks for in a New Team Member
(30:32) Most Rewarding Aspect of Working in Life Sciences
(32:21) Stay in Touch with J.D.
For more, check out the podcast website - www.lifesciencespod.com -
Use This Tech, Transform Science: Flow Meters w/ Bethany Silva
Are you interested in how the latest flow technology is transforming biopharmaceutical manufacturing?
Join us for Episode 40 of the Life Sciences 360 podcast, where Harsh Thakkar (@harshvthakkar), CEO of Qualtivate sits down with Bethany Silva (@bethany-silva), Life Sciences Industry Manager at Endress+Hauser.
They delve deep into the world of flow measurement, focusing on the cutting-edge single-use flow meters based on the Coriolis principle and how this technology is crucial for the development and production of biologics.
👍 Like this video if you find the advancements in biopharmaceutical manufacturing exciting.
💬 Comment below with your thoughts on how technology is shaping the future of medicine production.
🔔 Subscribe to our channel for more insights from industry leaders and experts in life sciences.
📲 Follow us on social media to stay updated with the latest trends and discussions in the biotech and pharmaceutical industry.
-----
Links:
*Endress + Hauser
*Would you rather watch the episode? Click here.
*Like & Subscribe to Life Sciences 360 YouTube Channel!
-----
Show Notes:
(0:00) Introduction to Flow Technology in Biopharmaceuticals
(1:17) Understanding Single-Use Flow Meters
(4:14) The Cost, Maintenance, and Calibration of Flow Meters
(10:10) Application Across Various Industries
(13:32) Future Trends in Flow Measurement Technology
(16:21) Advice for Aspiring Professionals in the STEM Field
(19:10) How to Approach Leadership
For more, check out the podcast website - www.lifesciencespod.com
Top Podcasts In Science
You Might Also Like